1.Study of Loss of Heterozygosity on Chromosome 9p21-22 in Sporadic Gliomas
Journal of Zhejiang University. Medical sciences 2001;30(2):87-89
Objective:To Search allele loss in glioma at chromesome 9p21-22 by microsatellite.Methods:Loss of heterozy gosi ty (LOH) and Microsatellite instability(MSI) was examined in 29 gliomas using PC R based methods.Results:No LOH and MSI on chromosome 9p21-22 was de tected in 29 gliomas at three loci.Conclusion:①There may be no othe r suppressor gene at 9p21-22 in glioma except p15 and p16.②MSI is infrequent i n sporadic gliomas.
2.Epstein-Barr virus-associated lymphoepithelioma-like intrahepatic cholangiocarcinoma:A report of 3 cases and literature review
Lushan PENG ; Xianchu PENG ; Saili DUAN ; Zhejia ZHANG
Journal of Central South University(Medical Sciences) 2024;49(2):319-329
Hepatic lymphoepithelioma-like carcinoma(LELC)is an extremely rare malignant tumor characterized by undifferentiated malignant epithelial cells and significant lymphatic infiltration.Hepatic LELC mainly includes lymphoepithelioma-like hepatocellular carcinoma(LEL-HCC)and lymphoepithelioma-like intrahepatic cholangiocarcinoma(LEL-CC).Epstein-Barr virus(EBV)infection is considered as an important factor in LELC carcinogenesis.Since 2005,Xiangya Hospital of Central South University has treated a total of 3 patients with EBV-associated LEL-CC,which all showed liver masses by CT scans.After surgical resection,the EBV encoded RNA(EBER)and CK19 expression in all 3 patients were positive,and pathological examination confirmed EBV-associated LEL-CC.Two patients had a good postoperative prognosis,while 1 patient received relevant immunotherapy and chemotherapy after surgery.Based on the analysis of existing literature,the author believes that hepatic LELC can be included in the classification of liver tumors,which will provide new ideas for the accurate diagnosis and treatment of hepatic LELC.
3.Risk factors for hypoparathyroidism after thyroidectomy.
Wenlong WANG ; Xinying LI ; Fada XIA ; Ning BAI ; Zhejia ZHANG
Journal of Central South University(Medical Sciences) 2019;44(3):315-321
To investigate the risk factors for hypoparathyroidism after thyroidectomy.
Methods: Clinical data of 492 patients, who underwent thyroidectomy from April 2015 to December 2016 from Xiangya Hospital of Central South University, were studied retrospectively. Chi-square test and multivariable logistic regression were performed to find the risk factors for postoperative hypoparathyroidism.
Results: The incidence of postoperative hypoparathyroidism was 43.5%, and the incidence of temporary and permanent hypoparathyroidism was 43.1% and 0.4%, respectively. Univariate analysis showed that tumor pathology, thyroidectomy types, the extent of lymph node dissection, application of carbon nanoparticles, and merged Hashimoto's thyroiditis were risk factors for postoperative hypoparathyroidism (all P<0.01). Logistic regression analysis showed that: thyroidectomy types (OR=0.149, 95% CI 0.078 to 0.28), the extent lymph node dissection (OR=0.779, 95% CI 0.617 to 0.983) and application of carbon nanoparticles (OR=1.729,
95% CI 1.067 to 2.801) were independent risk factors for postoperative hypoparathyroidism (all P<0.05).
Conclusion: Hypoparathyroidism is a common complication after thyroidectomy. The incidence of postoperative hypoparathyroidism is significantly increased in patients underwent total thyroidectomy and cervical lymph node dissection. Application of carbon nanoparticles intraoperatively can reduce the incidence of postoperative hypoparathyroidism.
Humans
;
Hypoparathyroidism
;
surgery
;
Postoperative Complications
;
Retrospective Studies
;
Risk Factors
;
Thyroid Neoplasms
;
Thyroidectomy